PHIA Koninklijke Philips N.V.

Philips teams with Air Ambulance Kent Surrey Sussex in first of its kind emergency response collaboration in the UK

Philips teams with Air Ambulance Kent Surrey Sussex in first of its kind emergency response collaboration in the UK

October 3, 2019 

  • Livestream of real-time patient data in the air enhances remote medical advice for receiving hospitals to better prepare for patient arrival on the ground

  • Philips RDT Enhanced Data Service (EDS) technology allows for secure encrypted patient data transmission

Amsterdam, the Netherlands and London, United Kingdom – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced (AAKSS) will equip all of its emergency service helicopters with the Philips RDT Tempus ALS [1] and Philips IntelliSpace Corsium web-based software platform. AAKSS, which makes nearly 2,500 life-saving missions a year, many requiring urgent transfer of patients to major trauma centers across London, Brighton and Southampton, will be the first Emergency Service in the UK to use this new life-saving technology.   

The collaboration with Philips RDT and Air Ambulance Kent Surrey Sussex (AAKSS) in the UK marks the first time anywhere in the world that Helicopter Emergency Service (HEMS) teams, which include a doctor and paramedic, can live stream patient medical information – including electrocardiogram (ECG), body temperature, heart rhythm, pulse and respiration rate and blood pressure - from the scene to the receiving hospital, as well as the on-call air ambulance team. Philips Enhanced Data Service (EDS) minimizes data packets to enhance reliability over low bandwidth preventing data loss during transmission.

“This collaboration recognizes our position as one of the world’s leading air ambulance services bringing the most sophisticated technology to support the highly skilled medical teams we deploy across Kent, Surrey and Sussex,” said David Welch, Chief Executive Officer of Air Ambulance Kent Surrey Sussex.  “This will have a very significant impact in helping us to save lives and improve patient outcomes across the south east. With AAKSS demonstrating its application in real-life situations, we are confident the technology will be adopted by other air ambulances and partners in the health service.”

Philips IntelliSpace Corsium web-based software platform

IntelliSpace Corsium expands the pre‐hospital scope of secure data-sharing and care wider than ever before. The Philips RDT Tempus ALS captures and transmits clinical and on-scene data to be shared and reviewed in a two‐way real-time consultation, to enhance decision making for AAKSS and other care givers. The Tempus ALS solution consists of the Tempus Pro portable, vital signs monitor, and the Tempus LS defibrillator. The monitor and defibrillator devices connect wirelessly together to share data and transfer patient vitals, waveforms and images into Philips IntelliSpace Corsium, a web-based software platform. This connectivity will provide the AAKSS with an interactive ECG measurement and two-way communication, enabling rapid clinical and transport decision support and seamless electronic patient care reporting (ePCR) integration.

"In emergency situations where every second counts, having the ability to livestream a patient’s physiology data from an incident scene - whether in route on the ground or in the air - offers a tremendous opportunity for our team to improve the outcomes for our patients,” said Dr. Richard Lyon, Associate Medical Director, Air Ambulance Kent Surrey Sussex. “This collaboration with Philips RDT allows our teams to give better remote medical advice for our receiving hospitals to better prepare for the patient's arrival. As a charity that continually strives to improve patient care through innovation, we are excited to be working with Philips RDT and see the positive benefit this novel technology will bring.”

“AAKSS takes an approach of innovation and thought leadership to help enhance patient outcomes through delivering the most effective patient care,” said Arman Voskerchyan, Business Leader of Therapeutic Care at Philips. “It’s exciting to collaborate with a team who visions that data—how it’s used, how it’s transmitted, and how it connects people and relevant information – and predictive analytics, derived from data, is the future of connected care. Connectivity and digital technology continue to drive how we are helping to save lives and improve patient care.”

Philips leadership in Emergency Care solutions

Philips RDT, a leading innovator of advanced solutions for the pre-hospital market providing monitoring, cardiac therapy and data management, in June 2018.  RDT’s portfolio of comprehensive connected emergency care solutions further strengthened Philips’ leadership position in the resuscitation and emergency care market. This latest example of teaming with  AAKSS further demonstrates Philips’ ability to innovate, drive digital transformation in healthcare, and enter new markets.

Philips offers a range of proven monitoring and therapeutic products and solutions to help emergency medical services, hospitals and lay responders accelerate the delivery of care at the scene. Technologies include  (AEDs), , and .  More information on Philips Emergency Care and Resuscitation is available . 

[1] Tempus ALS is a modular monitor/defibrillator system consisting of Tempus Pro monitor and Tempus LS defibrillator. Tempus LS is not available for sale in the USA.

For further information, please contact:

Kathy O'Reilly 

Philips Global Press Office

Mobile:

E-mail : 

Elizabeth Littlewood

Head of Brand and Communications Philips UKI

Tel: + 44 (0) 7909 874563

Email:

About Royal Philips

(NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2018 sales of EUR 18.1 billion and employs approximately 78,000 employees with sales and services in more than 100 countries. News about Philips can be found at . 

About Air Ambulance Kent Surrey Sussex

Founded in November 1989, Air Ambulance Kent Surrey Sussex (AAKSS) is one of the world’s leading Air Ambulance and Helicopter Emergency Medical Services at the forefront of utilizing technology and innovation to save lives and improve patient outcomes.  AAKSS serves a resident population of 4.7 million across South East England and millions more who pass through the region every year. Its highly skilled medical teams utilize state-of-the-art helicopters, emergency response vehicles, innovative technology and cutting-edge medical equipment and techniques to provide 24/7, world class, pre-hospital emergency medical treatment and care in all weather conditions. It works collaboratively with the wider ambulance service and more than 20 hospitals including several Major Trauma Centres in London.

Attachment

EN
03/10/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

Marc Hesselink ... (+2)
  • Marc Hesselink
  • CFA

Philips/Execution is key/HOLD

Philips reported a better-than-expected 4Q25 update and a supportive CMD message. We increase our estimates, raise our target price from €23 to €26 and reiterate our Hold rating. Philips appears positioned to continue progressing operationally, but we believe consistent delivery will be required before we see meaningful outperformance versus the sector. Valuation at 15x adj EPS 2027F is in line with peers.

 PRESS RELEASE

Philips unveils Rembra CT at ECR 2026, setting a new benchmark for spe...

Philips unveils Rembra CT at ECR 2026, setting a new benchmark for speed and patient access designed to support diagnostic confidence for acute and high-demand imaging environments March 4, 2026 CE Marked and 510(k) pending, Rembra’s advanced image reconstruction technology delivers up to 106 images per second [1] and a high throughput of up to 270 patients per day [2] to support faster diagnosis by making scans available in near-real timeWith the largest-in-class 85 cm bore, Rembra accommodates challenging patient types, providing more access for complex interventions, bariatric imaging a...

 PRESS RELEASE

Philips publishes its Annual Report 2025

Philips publishes its Annual Report 2025 February 19, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today published its Annual Report 2025. Philips’ Annual Report 2025 will be on the agenda of the Annual General Meeting of Shareholders (AGM), to be held on May 8, 2026. The convocation notice and the agenda, including explanatory notes, for the AGM will be published in due course. Philips filed the Annual Report 2025 with the Netherlands Authority for the Financial Markets (AFM) in European Single Electronic Format (ESEF) and expects to f...

 PRESS RELEASE

Philips introduces InkSpace Imaging’s Snuggle™ flexible pediatric MRI ...

Philips introduces InkSpace Imaging’s Snuggle™ flexible pediatric MRI coil for its 3.0T MR systems, helping to enhance imaging precision, efficiency and comfort February 12, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the availability of the InkSpace Imaging Snuggle™ pediatric body array coil for Philips 3.0T MRI systems. Designed specifically for pediatric patients, the Snuggle coil has been optimized and validated for use with Philips 3.0T MRI systems, bringing enhanced comfort for children and efficient, high-quality i...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

ABN Amro: Miss but strong capital, good set of results / Ahold Delhaize: Strong 4Q25 but no major surprise on FY26 adj. EPS guidance / Alfen: No recovery yet and another transitional year / BAM Group: Preview: 2026 outlook the key item / Econocom: Better REBITA, net debt, but EBIT below, much lower net profit, dividend halved, 2026-28 guidance postponed to “medium term” / Exor: Ferrari 4Q25 and 2026 guidance beat / Gecina: Results and guidance in line, DPS set to grow over 2026-30 / Heineken: No...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch